Phospholamban and cardiac contractile function

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 12, 2000, Pages 2131-2139

  Brittsan, Angela G ^a   Kranias, Evangelia G ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac contractility; Phospholamban; Sarcoplasmic reticulum; Adrenergic stimulation

Indexed keywords

CALCIUM; CALMODULIN; PHOSPHOLAMBAN;

BETA ADRENERGIC STIMULATION; CALCIUM HOMEOSTASIS; CARDIOMYOPATHY; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 0034509410     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1270     Document Type: Review

References (69)

1. 2+ pump of sarcoplasmic reticulum
2. Functional reconstitution of the cardiac sarcoplasmic reticulum Ca2(+)-ATPase with phospholamban in phospholipid vesicles
3. Effects of adenosine 3′: 5′-monophosphate-dependent protein kinase on sarcoplasmic reticulum isolated from cardiac and slow and fast contracting skeletal muscles
4. Phospholamban expressed in slow-twitch and chronically stimulated fast-twitch muscles minimally affects calcium affinity of sarcoplasmic reticulum Ca(2+)-ATPase
5. 2+ pump of bovine pulmonary artery
6. Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation. Evidence from phospholamban gene-ablated mice
7. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains
8. Effects of phospholamban phosphorylation catalyzed by adenosine 3′:5′-mono-phosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum
9. Phosphorylation of phospholamban by calcium-activated phospholipid-dependent protein kinase. Stimulation of cardiac sarcoplasmic reticulum calcium uptake
10. 2+ transport by cyclic 3′.5′-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum
11. A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum
12. Autonomic regulation of type 1 protein phosphatase in cardiac muscle
13. Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels. Evidence for a protein structure consisting of multiple identical phosphorylatable subunits
14. Amino acids Glu2 to Ile18 in the cytoplasmic domain of phospholamban are essential for functional association with the Ca(2+)-ATPase of sarcoplasmic reticulum
15. 2+-ATPase through intramembrane interactions
16. 2+-ATPase isoform of cardiac sarcoplasmic reticulum
17. Phospholamban inhibitory function is activated by depolymerization
18. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice
19. Phospholamban gene dosage effects in the mammalian heart
20. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation
21. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency
22. 2+
23. Regulatory effects of phospholamban on cardiac function in intact mice
24. Amount of calcium in the sarcoplasmic reticulum: Influence on excitation-contraction coupling in heart muscle
25. Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase
26. Phospholamban: A prominent regulator of myocardial contractility
27. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban
28. Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation
29. Intracellular mechanisms mediating reversal of beta-adrenergic stimulation in intact beating hearts
30. 2+-ATPase activity in guinea pig ventricles
31. Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts
32. beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts
33. Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation
34. 2+-calmodulin-dependent mechanisms
35. cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts
36. Transgenic approaches to define the functional role of dual site phospholamban phosphorylation
37. Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart
38. Frequency-encoding Thr 17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes
39. Depolymerization of phospholamban in the presence of calcium pump: A fluorescence energy transfer study
40. Structural organization of the pentameric transmembrane alpha-helices of phospholamban, a cardiac ion channel
41. A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure
42. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation
43. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers
44. Monomeric phospholamban overexpression in transgenic mouse hearts
45. The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility
46. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo
47. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins
48. 2+ transport and myocardial relaxation
49. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts
50. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions
51. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart
52. 2+ ATPase and decreasing phospholamban expression
53. Thyroid hormone control of contraction and the Ca(2+)-ATPase/phospholamban complex in adult rat ventricular myocytes
54. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure
55. Altered calcium uptake by the sarcoplasmic reticulum following cardiac transplantation in humans
56. 2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts
57. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy
58. Regulation of sarcoplasmic reticulum Ca(2+)-ATPase and phospholamban in the failing and nonfailing heart
59. Human heart failure: cAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban
60. Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation
61. Increased expression of cardiac phosphatases in patients with end-stage heart failure
62. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
63. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a
64. Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility
65. Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: Comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter
66. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
67. Rescue of the depressed contractile parameters in calsequestrin overexpressing hearts by phospholamban ablation
68. Pathogenesis of dilated cardiomyopathy: Molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice
69. Re-evaluating sarcoplasmic reticulum function in heart failure